China's Sinovac COVID-19 Vaccine CoronaVac Registered For Use In South Africa

Sinovac Biotech Ltd. (SVA) announced that the South African Health Products Regulatory Authority or SAHPRA granted conditional registration to Chinese COVID-19 vaccine CoronaVac. It is administered by intramuscular injection in two doses between 14-28 days apart from the initial dose for individuals 18-59 years of age.

SAHPRA registered CoronaVac with conditions on June 14, 2022. The conditions include that the vaccine is supplied and administered in accordance with South Africa's National Department of Health COVID-19 vaccination plan and applicable guidelines.

SINOVAC stated that its COVID-19 vaccine has been available in more than 60 countries, with a total supply of almost 2.9 billion doses. The CoronaVac(r) was previously authorized for emergency use with conditions by the SAHPRA on July 3, 2021.

Subsequent to the approval, SINOVAC said it is reporting the results of ongoing studies and submitting periodic safety updates. All the evidence suggested that the SINOVAC COVID-19 vaccine was safe and effective, the company stated.

The CoronaVac is an inactivated SARS-CoV-2 virus (CZo2 strain) to prevent COVID-19 caused by SARS-CoV-2 virus. The most common side effects were pain at the injection site, headache, tiredness, muscle pain and nausea, which were usually mild or moderate and cleared within a few days after vaccination, SAHPRA specified.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Ride-hailing company Lyft announced its foray into the media and advertisement business with the launch of Lyft Media as part of its vision to build the world's largest transportation media network. Lyft Media has built a suite of new products to allow advertisers to engage with Lyft's growing audience throughout their transportation journeys. Sysco Corp. (SYY) Tuesday reported a more than a three-times surge in fourth-quarter earnings, supported by 17.5 percent growth in sales. The company projects fiscal 2023 adjusted earnings to grow. Earnings for the quarter spiked to $509.99 million from $151.09 million last year. On a per share basis,... Longmont Colorado -based Royal Crest Dairy is recalling 2% Chocolate Milk citing the potential to be contaminated with undeclared egg, a known allergen, the U.S. Food and Drug Administration said. The recall involves Farmer's 2% Reduced Fat Chocolate Milk Pints with the code date of AUG-22.
Follow RTT